
Otsuka Pharmaceutical Co., Ltd. hereby declares that as company committed to the betterment of human life we will conduct business activities with proper regard for our impact on the global environment and local community, and that we will take practical and positive steps to address environmental issues.
Being based on our corporate philosophy "Otsuka-people creating new products for better health worldwide" we commit ourselves, as a responsible corporate citizen that regards global environment as of vital concern, to actively address environmental issues through our business activities aiming to contribute to health of people of the whole world over as well as to the preservation of global environment keeping progressive postures in our deed.
We prepare appropriate risk management procedures and draw up risk management plans to establish and implement risk management system against emergency accidents and the state of emergency.
All the 6 production sites of Otsuka Pharmaceutical Co., Ltd.(OPC) obtained ISO 14001 certification during the years 2000 and 2003. The companies of consolidated accounting also have positioned ISO 14001 certification as the basic tool of environmental management to promote continuous improvement in addressing environmental issues. As of the end of March, 2007 13 sites in Japan and 2 overseas sites of the companies have obtained ISO 14001 certification.






Otsuka Pharmaceutical Co., Ltd.’s environmental objectives, results and achievements of the year 2006 are summarized below:
| Item | FY2006 Targets and Objectives |
FY2006 Results and Achievements |
|---|---|---|
| Environmental Management System | ISO Re-registration(3sites) ISO Periodic Audit(3sites) |
ISO Re-registration(3sites) ISO Periodic Audit(3sites) |
| Mitigation of Global Warming/Energy Saving | Reduction of CO2 emission rate (20% from FY 1990). | Reduced CO2 emission rate* by 18% from FY 1990 level *rate: tons (volume of emissions)/100 M yen (gross sales) |
| Waste Disposal | Reduction of landfill waste by over 91% from FY 1996 level Recycle over 70% of sludge |
Reduced landfill waste by 92% from FY 1996 level Recycled 96% of sludge |
| Control of Chemical Substances | Reduction of organochlorine solvent emission by 50% from FY 2000 levels | Reduced organochlorine solvent emission by 38.9% from FY 2000 levels |
| Green Procurement | Increase items to be over 70% (Purchased ratio in amount) | Increased items to be 84% (Purchased ratio in amount) |
| Environmental Education | Increase opportunities and improve standard of education | Internal auditor course 14 Environmental qualifications 10 Induction course 111 Training/Test 348 (Number of persons) |
| Regulatory Compliance | Establishment and compliance of higher standard of voluntary regulations | One offence at one site No other regulatory nor voluntary standard offence at any other sites |
| Social Contribution | Aggressive performance of supporting activities Increase communicative opportunities with neighboring communities Participation in voluntary clean-up activities Acceptance of factory tours |
Supporting activities 11 times Communication with the neighboring 28 times Clean-up activity 924 persons Factory tour participants 38,466 persons |
The total energy (converted in joules) consumed through business activities of Otsuka Pharmaceutical Co., Ltd in FY 2006 amounted to 969,012GJ and 67% of which was purchased electricity. Energy saving activities included operational improvement of air conditioning and cooling equipments at research facilities as well as production sites and highly efficient equipments were adopted at various sites.

CO2 emission per unit of sales in our business activities in FY 2006 showed 12.4 ton/hundred million of sales (reduced by 18.1% from 1990 level) and failed to achieve our annual target. And the total volume of CO2 emission increased by 7.2% from the previous year due to the commencement of newly equipped production lines.

Otsuka Pharmaceutical Co., Ltd. is focusing particularly on organochlorine solvents in our continuous efforts to reduce emissions of harmful chemical substances. In FY 2006 the total emission volume of organochlorine solvents amounted to 2,012kg (reduced by 38.9% from FY 1990 levels). However, the figure was below our annual target of Reduction by 50% from FY 2000 levels due to partial improperness of recovery equipment system. We are to improve recovery equipment system and at the same time reinforce management structure in order to increase recovery ratio.


In FY 2006, the total volume of waste substances from the business activities of six OPC factories in Japan was 4,927 tons which exceeds that of the previous year by 84% due to the commencement of operation of newly equipped production lines. Of the total volume only 138 tons (reduced by 45% from the previous year) of waste was brought to landfills which represents 91.6% of reduction from FY 1996.

Otsuka Pharmaceutical Co., Ltd. which produces a wide variety of products such as pharmaceuticals, cosmetics, beverages and foods is developing every product from a standpoint of 3Rs (Reduce/Reuse/Recycle) as well. We are also working to build effective recycling systems through various associations and industry groups involved in container recycling. In every area of our business field including pharmaceuticals, we are committed to ongoing technology development to supply products with less environmental impact.
A good example of lightweight and easy-to-recycle container which contributes to resource/energy savings and reduction of CO2 emission is "ECOBOTTLE" for Pocari Sweat 500ml PET bottle. The bottle of the product which was launched into the market just recently weighs only 18g to be the lightest of the kind in Japanese market. This has been realized through a new technology of "positive pressure aseptic filling".

This section represents selections of the activities performed by Otsuka Pharmaceutical Co., Ltd. in the fiscal year 2006.